C

CSPC Pharmaceutical Group Ltd
HKEX:1093

Watchlist Manager
CSPC Pharmaceutical Group Ltd
HKEX:1093
Watchlist
Price: 4.8 HKD -0.21% Market Closed
Market Cap: 56.1B HKD
Have any thoughts about
CSPC Pharmaceutical Group Ltd?
Write Note

CSPC Pharmaceutical Group Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CSPC Pharmaceutical Group Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Effect of Foreign Exchange Rates
ÂĄ178k
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Effect of Foreign Exchange Rates
-ÂĄ122.4m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Effect of Foreign Exchange Rates
ÂĄ5.2m
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
3%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Effect of Foreign Exchange Rates
-ÂĄ28.4m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Effect of Foreign Exchange Rates
-ÂĄ5.3m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
-15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Effect of Foreign Exchange Rates
-ÂĄ2.6m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CSPC Pharmaceutical Group Ltd
Glance View

Market Cap
57.1B HKD
Industry
Pharmaceuticals

CSPC Pharmaceutical Group Ltd., a prominent player in the pharmaceutical industry, has charted a strategic path focused on innovation and a diversified portfolio. The company, with its roots in China, has emerged as a formidable force by blending traditional pharmaceutical manufacturing with a strong emphasis on research and development. CSPC's journey is characterized by a commitment to developing high-quality generic drugs, innovative therapeutics, and nutritional products. The company's core business revolves around the production and sale of a wide range of pharmaceuticals, including cardiovascular drugs, oncology treatments, and central nervous system therapies. By leveraging advanced technology and robust research initiatives, CSPC consistently delivers solutions that address both common and complex healthcare needs across the globe. With a strategic focus on both domestic and international markets, CSPC Pharmaceutical Group capitalizes on its extensive distribution network to maximize reach and impact. The company has made significant investments in its production capabilities to maintain stringent quality standards while achieving cost efficiency. Furthermore, CSPC's earnings are bolstered by its expanding pipeline of innovative drugs, developed in-house and through strategic collaborations, which aims to capture emerging therapeutic areas. Overall, CSPC's blend of traditional pharmaceutical expertise, a focus on innovation, and strategic market positioning enables it to maintain a strong operational foothold and to consistently drive revenue growth in an ever-evolving industry landscape.

Intrinsic Value
7.28 HKD
Undervaluation 34%
Intrinsic Value
Price
C

See Also

What is CSPC Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
178k CNY

Based on the financial report for Sep 30, 2024, CSPC Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates amounts to 178k CNY.

What is CSPC Pharmaceutical Group Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
-39%

Over the last year, the Effect of Foreign Exchange Rates growth was -98%.

Back to Top